Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Published Online
on July 14, 2003

Circulation. 2003
Published online before print July 14, 2003, doi: 10.1161/01.CIR.0000080339.49212.49
A more recent version of this article appeared on July 29, 2003
This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
108/4/464    most recent
01.CIR.0000080339.49212.49v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mnjoyan, Z. H.
Right arrow Articles by Fujise, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mnjoyan, Z. H.
Right arrow Articles by Fujise, K.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
*Genetics Home Reference
Related Collections
Right arrow Pathophysiology

Submitted on December 19, 2002
Revised on March 20, 2003
Accepted on April 14, 2003

Paradoxical Upregulation of Tumor Suppressor Protein p53 in Serum-Stimulated Vascular Smooth Muscle Cells. A Novel Negative-Feedback Regulatory Mechanism

Zakar H. Mnjoyan PhD, Ranjan Dutta PhD, Di Zhang MS, Ba-Bie Teng PhD, and Ken Fujise MD*

From the Research Center for Cardiovascular Diseases (Z.H.M., D.Z., K.F.) and the Research Center for Human Genetics (R.D., B.-B.T.), Institute of Molecular Medicine for the Prevention of Human Diseases, and the Division of Cardiology, Department of Internal Medicine (K.F.), The University of Texas-Houston Health Science Center.

* To whom correspondence should be addressed. E-mail: kenichi.fujise{at}uth.tmc.edu.

Background--The proliferative response of vascular smooth muscle cells (VSMCs) to various growth stimuli is critical for atherosclerosis and postangioplasty restenosis. Although tumor suppressor protein p53 plays a critical role in the elimination of cancerous cells, recent genetic studies have indicated that it also protects against atherosclerosis and restenosis.

Methods and Results--We examined the levels of p53 protein in normal VSMCs before and after serum stimulation. The p53 protein levels increased robustly on stimulation. Upregulated p53 protein was capable of binding to the p53 consensus sequence, as shown by electrophoretic mobility shift assay. In addition, p53 upregulation was associated with increases in the transcript and protein levels of p21WAF1/CIP1 and Bax, as shown by real-time reverse transcriptase-polymerase chain reaction and Western blot analysis, respectively. Furthermore, the upregulation of p21WAF1/CIP1 and Bax was followed by cell-cycle arrest and apoptosis induction, as shown by 5-bromo-2`-dUTP incorporation assay and terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling staining, respectively. Finally, double-staining analyses showed that the majority of p53-expressing cells also expressed p21WAF1/CIP1 and Bax proteins.

Conclusions--p53 protein expression in quiescent VSMCs is paradoxically increased by application of a growth stimulus. Through the mediation of p21WAF1/CIP1 and Bax, the induced p53 protein negatively regulates the growth of dividing VSMCs, thereby minimizing the inappropriate accumulation of VSMCs. Therefore, p53 may be a negative regulator of VSMC growth.


Key words: angioplasty • restenosis • atherosclerosis • growth substances • apoptosis




This article has been cited by other articles:


Home page
Eur Heart JHome page
D. Pons, F. R. de Vries, P. J. van den Elsen, B. T. Heijmans, P. H.A. Quax, and J. W. Jukema
Epigenetic histone acetylation modifiers in vascular remodelling: new targets for therapy in cardiovascular disease
Eur. Heart J., February 1, 2009; 30(3): 266 - 277.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
D. G. Sedding, M. Homann, U. Seay, H. Tillmanns, K. T. Preissner, and R. C. Braun-Dullaeus
Calpain counteracts mechanosensitive apoptosis of vascular smooth muscle cells in vitro and in vivo
FASEB J, February 1, 2008; 22(2): 579 - 589.
[Abstract] [Full Text] [PDF]